A 2024 study from Scandinavia analyzed data from 145,000 patients who received GLP-1 receptor agonists in Denmark, Norway, and Sweden
Endocrinologists and cardiologists in major cities are gaining experience with GLP-1 medications through diabetes management applications, facilitating confidence in prescribing for obesity indications
This guide covers everything researchers need to know: the current approval status, every TRIUMPH trial and what the data shows, the new safety signals that emerged, realistic timeline projections, and how retatrutide stacks up against the GLP-1 medications already on the market
Womens Health (Lond)
To help reduce gastrointestinal irritation, it excludes common triggers like spicy foods, mint, and chocolate, and it follows a gluten-free, dairy-free, egg-free, and corn-free structure to support people with multiple sensitivities
Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California